| 0 (0%) | 09-27 09:34 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 26.67 | 1-year : | 27.89 |
| Resists | First : | 22.84 | Second : | 23.87 |
| Pivot price | 22.12  |
|||
| Supports | First : | 21.16 | Second : | 17.6 |
| MAs | MA(5) : | 21.62 |
MA(20) : | 22.43 |
| MA(100) : | 22.33 |
MA(250) : | 20.38 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 12.9 |
D(3) : | 12.7 |
| RSI | RSI(14): 42.3 |
|||
| 52-week | High : | 26.76 | Low : | 13.39 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ PGNY ] has closed above bottom band by 21.5%. Bollinger Bands are 0% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 21.75 - 21.85 | 21.85 - 21.94 |
| Low: | 21.08 - 21.2 | 21.2 - 21.3 |
| Close: | 21.28 - 21.47 | 21.47 - 21.63 |
Thu, 25 Sep 2025
Progyny (NASDAQ:PGNY) Is Doing The Right Things To Multiply Its Share Price - Yahoo Finance
Tue, 23 Sep 2025
A Fresh Look at Progyny (PGNY) Valuation Following Expanded Fertility Benefits With Fellow Health - simplywall.st
Tue, 23 Sep 2025
A Fresh Look at Progyny (PGNY) Valuation Following Expanded Fertility Benefits With Fellow Health - Sahm
Tue, 23 Sep 2025
Voya Investment Management LLC Buys 133,703 Shares of Progyny, Inc. $PGNY - MarketBeat
Sun, 21 Sep 2025
Did At-Home Semen Testing Integration Just Shift Progyny's (PGNY) Competitive Edge in Fertility Care? - simplywall.st
Wed, 17 Sep 2025
AQR Capital Management LLC Purchases 303,750 Shares of Progyny, Inc. $PGNY - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 86 (M) |
| Shares Float | 80 (M) |
| Held by Insiders | 7.5 (%) |
| Held by Institutions | 103.9 (%) |
| Shares Short | 6,950 (K) |
| Shares Short P.Month | 7,760 (K) |
| EPS | 0.58 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.03 |
| Profit Margin | 4.2 % |
| Operating Margin | 7.3 % |
| Return on Assets (ttm) | 6.5 % |
| Return on Equity (ttm) | 10.9 % |
| Qtrly Rev. Growth | 9.5 % |
| Gross Profit (p.s.) | 3.22 |
| Sales Per Share | 14.42 |
| EBITDA (p.s.) | 0.93 |
| Qtrly Earnings Growth | 11.8 % |
| Operating Cash Flow | 202 (M) |
| Levered Free Cash Flow | 195 (M) |
| PE Ratio | 36.37 |
| PEG Ratio | 0 |
| Price to Book value | 3.55 |
| Price to Sales | 1.48 |
| Price to Cash Flow | 9.13 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|